<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Antimitochondrial type M5 antibodies (AMA-M5) are among the <z:hpo ids='HP_0002715'>immunological abnormalities</z:hpo> associated with <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>CASE: A 45 year-old woman, hospitalized for <z:hpo ids='HP_0000651'>diplopia</z:hpo> and with a 20-year history of obstetrical accidents, internuclear <z:hpo ids='HP_0000602'>ophthalmoplegia</z:hpo> and livedo, was diagnosed with <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon syndrome</z:e> associated with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (APS) aggravated by the presence of AMA-M5 </plain></SENT>
<SENT sid="2" pm="."><plain>DISCUSSION: AMA-M5 are immunological markers of APS to the same extent as <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>This case demonstrates the interest of screening for AMA-M5 in cases of strong clinical suspicion of APS when the <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> test is <z:mpath ids='MPATH_458'>normal</z:mpath> and no anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi>, anti-b2 <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I or antiprothrombin antibodies are found </plain></SENT>
</text></document>